DEA
| HOME | PRIVACY POLICY | CONTACT US | SITE DIRECTORY |
Skip Navigation

Global News Local News

 News from DEA
   News Releases
   Speeches & Testimony
   Photo Library
   Audio/Video Library
   FOIA

 Briefs & Background
 Drug Trafficking & Abuse
   Drug Information
   Prescription Drug Info.
   Drug Trafficking
   State Factsheets
 Law Enforcement
   Recent Cases
   Major Operations
   Intelligence Reports
   DEA Fugitives
   Training Opportunities
   Statistics
 Drug Policy
   Controlled Substances Act
   Federal Trafficking Penalties
   Drug Scheduling
 DEA Resources
   For Contractors
   For Job Applicants
   For Law Enforcement
   For Legislators
   For Parents & Teachers
   For Physicians/Registrants
   For Students
   For Victims of Crime

 Inside the DEA
   DEA's Mission
   DEA Leadership
   Programs & Operations
   Publications Library
   DEA Museum
   Staffing & Budget
   Office Locations
   DEA History
   DEA Wall of Honor
   Office of Diversion
   Acquisitions & Contracts
   DOJ Homepage


[print friendly page]

Chloral Hydrate

The oldest of the hypnotic (sleep inducing} depressants, chloral hydrate was first synthesized in 1832. Marketed as syrups or soft gelatin capsules, chloral hydrate takes effect in a relatively short time (30 minutes) and will induce sleep in about an hour. A solution of chloral hydrate and alcohol constituted the infamous "knockout drops" or "Mickey Finn." At therapeutic doses, chloral hydrate has little effect on respiration and blood pressure; however; a toxic dose produces severe respiratory depression and very low blood pressure. Chronic use is associated with liver damage and a severe withdrawal syndrome. Although some physicians consider chloral hydrate to be the drug of choice for sedation of children before diagnostic, dental, or medical procedures, its general use as a hypnotic has declined. Chloral hydrate (Noctec® and other) and compounds, preparations, or mixtures containing choral hydrate are in Schedule IV of the CSA.

 
www.dea.gov